Global Steerable Needles Market - 2023-2030

Global Steerable Needles Market - 2023-2030

Global steerable needles market reached US$ YY million in 2022 and is expected to reach US$ YY million by 2030, growing at a CAGR of YY% during the forecast period 2023-2030.

Steerable needles are a cutting-edge medical technology that aims to enhance the precision and control of minimally invasive surgical procedures. These devices feature flexible tips that can be guided and controlled by medical professionals, allowing for more accurate navigation through complex anatomical structures.

Steerable needles have a wide range of applications, from delivering targeted therapies and obtaining tissue samples to performing biopsies and conducting interventions in challenging, hard-to-reach areas of the body.

Their ability to adapt to the specific needs of a procedure and navigate through intricate pathways offers the potential to improve patient outcomes, reduce tissue damage, and minimize the invasiveness of medical interventions. Steerable needles represent a promising advancement in the field of minimally invasive surgery, with the potential to revolutionize various medical specialities.

Market Dynamics: Drivers and Restraints

Advancements in enabling accurate steerable needle deployment in vivo are expected to drive market growth

A study published in Science Robotics in September 2023 revealed a major advancement in medical robotics. Researchers developed an autonomous system that can steer a medical needle through living tissue around anatomical obstacles with precision. The system makes use of a flexible steerable needle, which can navigate through curved paths to avoid obstacles and reach regions that are otherwise hard to access using traditional straight instruments. Manually inserting a steerable needle is challenging, making robotic autonomous actuation crucial.

The autonomous deployment of the steerable needle can standardize patient care and improve the accuracy of existing medical procedures. The robot autonomously deploys the needle along a planned trajectory to the target while avoiding obstacles. This technology has the potential to revolutionize the way medical procedures are performed and enable new procedures with increased accuracy. The development of an autonomous medical needle steering system is a significant advancement in the field of medical robotics.

Restraint:

High cost, limited reimbursement policies, lack of skilled professionals, and potential risks associated with the use of steerable needles are the factors expected to hamper the market over the forecast period.

For more details on this report – Request for Sample

Segment Analysis

The global steerable needles market is segmented based on product type, steering techniques, application, end-user and region.

The active steerable needles from the product type segment accounted for approximately 56.4% of the steerable needles market share

Active steerable needles are advanced medical devices equipped with integrated mechanisms such as robotics, sensors, or other technologies, designed for minimally invasive procedures. These devices enable healthcare professionals to adjust and control them in real time, providing enhanced precision and adaptability during surgical interventions.

They are useful in navigating complex anatomical structures with reduced tissue damage. These needles are used in various applications, including targeted drug delivery, biopsy procedures, and minimally invasive surgeries.

The market for active steerable needles is driven by increasing demand for precise and minimally invasive techniques, technological advancements, the growing prevalence of complex medical conditions and increasing FDA approvals.

For instance, on September 7, 2022, Serpex Medical received clearance from the U.S. FDA 510(k) for its Compass Steerable Needles. These are steerable biopsy needles that provide precise access to lung nodules in the intrapulmonary region. Serpex Medical aims to enhance the accuracy and accessibility of lung cancer diagnosis and treatment through steerable instruments. The approval of the Compass Steerable Needles comes after the Recon Steerable Sheath was also granted clearance by Serpex.

Furthermore, the leading manufacturers in the field, such as Cambridge BiomedTech, FlexDex, and Boston Scientific, are developing innovative steerable needle technologies. These technologies aim to improve patient outcomes and expand the scope of minimally invasive surgery. Hence, owing to the above factors the market segment is expected to hold the largest market share over the forecast period.

Geographical Analysis

North America accounted for approximately 42.5% of the market share in 2022

North America is expected to hold the largest market share, owing to the increasing number of ablation procedures, increased number of biopsy procedures, the rising adoption of steerable needles in hospitals for diagnosis and treatment of disease, and the presence of major players in the region.

For instance, the City of Hope Article published in 2022, stated that approximately 20% of breast biopsies conducted in the US result in a diagnosis of breast cancer. More than half of these biopsies employ core needle techniques, which is expected to drive the demand for steerable needles.

Additionally, on May 8, 2020, a new clinical trial revealed the results of using a novel energy source, pulsed-field ablation (PFA), to treat paroxysmal or persistent atrial fibrillation (AF). This was the first time PFA was used in humans, and the results demonstrate the safety and effectiveness of using this method to target abnormal heart rhythms through pulmonary vein isolation (PVI). Ablation is a common treatment for AF patients, with approximately 75,000 ablation procedures performed annually in the United States alone. The procedure uses PVI to ablate, or eliminate, the cause of irregular heartbeats.

COVID-19 Impact Analysis

The steerable needles market was significantly impacted by the COVID-19 pandemic, presenting both challenges and opportunities for this industry. Due to delays in elective surgeries and the shift in healthcare priorities towards addressing the immediate crisis, the market faced disruptions. Consequently, there was a temporary slowdown in the adoption of steerable needles for non-urgent and elective procedures as healthcare resources were redirected towards the COVID-19 response.

During the pandemic, the importance of minimally invasive procedures and precision in medical interventions became even more evident. Steerable needles, with their ability to minimize tissue damage and improve accuracy, played a crucial role in ensuring efficient patient care in the context of limited healthcare resources. The focus on minimizing patient exposure and reducing the duration of procedures contributed to the resilience of the steerable needles market.

Moreover, the pandemic hastened the adoption of telemedicine and remote monitoring, which led to the development of remotely guided steerable needles that can be controlled by medical professionals from a distance. The steerable needles market responded to this shift in healthcare delivery by exploring innovative solutions that align with the changing landscape of medical practice.

Although COVID-19 initially caused disruptions in the steerable needles market due to delays in elective procedures, it also emphasized the significance of minimally invasive and precise interventions. The market has adapted by exploring new technologies and approaches to meet the evolving needs of healthcare in the post-pandemic era.

Market Segmentation:

By Product Type
• Active Steerable Needles
• Passive Steerable Needles

By Steering Techniques
• Base Manipulation
• Bevel Tip Steering
• Precurved Stylet Steering
• Active Cannula (AC) Steering
• Programmable Bevel Steering
• Tendon Actuated Tip Steering

By Application
• Interventional Radiology
• Neurosurgery
• Gastrointestinal Surgery
• Cardiology
• Urology
• Robotic Assisted Surgery
• Others

By End-User
• Hospitals and Clinics
• Ambulatory Surgical Centers (ASCs)
• Diagnostic Centers
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the steerable needles market include AprioMed, Inc., Boston Scientific Corporation, Merit Medical Systems, APT Medical Inc., Serpex Medical, Medtronic, Integer Holdings Corporation, and SATT CONECTUS among others.

Key Development
• On September 7, 2022, Serpex Medical received clearance from the U.S. FDA 510(k) for its Compass Steerable Needles, which are steerable biopsy needles that allow for precise access to lung nodules in the intrapulmonary region. Serpex Medical aims to leverage the power of steerable instruments to improve the diagnosis and treatment of lung cancer by enabling greater precision and access. The clearance of the Compass Steerable Needles follows the recent clearance of Serpex's Recon Steerable Sheath.
• In 2021, Vanderbilt's research team was granted $2 million by the National Institutes of Health to further develop a robotic surgery system the size of a needle. The system will use real-time MRI guidance to treat drug-resistant temporal lobe epilepsy (TLE).

Why Purchase the Report?
• To visualize the global steerable needles segmentation based on product type, steering techniques, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of steerable needles market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global steerable needles market report would provide approximately 63 tables, 73 figures, and 189 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies